{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:45Z","timestamp":1707525165895},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"DOI":"10.7759\/cureus.40477","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T22:12:32Z","timestamp":1686867152000},"source":"Crossref","is-referenced-by-count":0,"title":["A Sweet Paradox: Severe Insulin Resistance and Hyperglycemia in Asymptomatic COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Bhanvi P","family":"Ramchandani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbah F","family":"Azmath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snigdha R","family":"Bendaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faryal S","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","year":"2021","unstructured":"Classification and diagnosis of diabetes. standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S15-33. 10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti K","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021, 44:2645-55. 10.2337\/dc21-1318","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.09.009","article-title":"Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2","volume":"33","author":"Reiterer M","year":"2021","unstructured":"Reiterer M, Rajan M, G\u00f3mez-Banoy N, et al.. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021, 33:2174-2188.e5. 10.1016\/j.cmet.2021.09.009","journal-title":"Cell Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.695139","article-title":"A machine-generated view of the role of blood glucose levels in the severity of COVID-19","volume":"9","author":"Logette E","year":"2021","unstructured":"Logette E, Lorin C, Favreau C, et al.. A machine-generated view of the role of blood glucose levels in the severity of COVID-19. Front Public Health. 2021, 9:695139. 10.3389\/fpubh.2021.695139","journal-title":"Front Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2271_20","article-title":"Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: a case series","volume":"10","author":"Downes JM","year":"2021","unstructured":"Downes JM, Foster JA. Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: a case series. J Family Med Prim Care. 2021, 10:2041-3. 10.4103\/jfmpc.jfmpc_2271_20","journal-title":"J Family Med Prim Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu L","year":"2020","unstructured":"Zhu L, She ZG, Cheng X, et al.. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020, 31:1068-77.e3. 10.1016\/j.cmet.2020.04.021","journal-title":"Cell Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0022","article-title":"Managing hyperglycemia in the COVID-19 inflammatory storm","volume":"69","author":"Gianchandani R","year":"2020","unstructured":"Gianchandani R, Esfandiari NH, Ang L, Iyengar J, Knotts S, Choksi P, Pop-Busui R. Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes. 2020, 69:2048-53. 10.2337\/dbi20-0022","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.01.015","article-title":"A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India","volume":"15","author":"Gupta Y","year":"2021","unstructured":"Gupta Y, Goyal A, Kubihal S, Golla KK, Tandon N. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India. Diabetes Metab Syndr. 2021, 15:407-13. 10.1016\/j.dsx.2021.01.015","journal-title":"Diabetes Metab Syndr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/151013-a-sweet-paradox-severe-insulin-resistance-and-hyperglycemia-in-asymptomatic-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:31Z","timestamp":1707508951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/151013-a-sweet-paradox-severe-insulin-resistance-and-hyperglycemia-in-asymptomatic-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.40477","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}